2025 fourth_quarter Filing
Q4Income
$70K
Filed
January 20, 2026
Lobbying Activities
Health IssuesView all
Issues related to mental health. Issues related to SUPPORT Act Reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.
Contacted:Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
Medicare/MedicaidView all
Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. Issues related to Most Favored Nation drug pricing.
Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Lobbyists (5)
MARY BETH SAVARY TAYLOR
GREG D'ANGELO
BRETT BAKER
RACHEL JONES HENSLER